查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585663

生物過程分析儀市場：按類型、應用和最終用戶分類 - 2025-2030 年全球預測

Bioprocess Analyzers Market by Type (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilars, Recombinant Proteins), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物過程分析儀市值為5.2167億美元，預計到2024年將達到5.8142億美元，複合年成長率為11.54%，預計到2030年將達到11.2104億美元。

生物製程分析儀是生物製藥製造中使用的關鍵儀器，透過監測 pH、溶解氧和細胞密度等變數來確保產品品質和一致性。嚴格的監管要求和生物製程技術日益複雜性加劇了對這些分析儀的需求。應用於生物製藥、食品飲料、環境等領域的研發、製程監控及品管。最終用途範圍包括生物製造、研究實驗室和致力於最佳化產量並遵守良好生產規範 (GMP) 的製藥公司。市場成長的推動因素是慢性病的增加對生技藥品的需求增加以及製程分析技術的改進所帶來的技術進步。新興市場的生物製藥基礎設施不斷擴大、個人化醫療的出現以及一次性技術的日益成長趨勢提供了可行的機會。然而，初始成本高、對熟練人員的需求以及整合的複雜性等挑戰是主要障礙。為了利用成長機會，公司應專注於即時和現場分析解決方案的創新、提高自動化程度以及減少製程監控中人為干預的解決方案。利用人工智慧和機器學習的增強型資料分析工具還可以提供更深入的見解和預測能力，推動更主動的流程最佳化。該市場充滿活力且競爭激烈，其特點是生物製藥公司與技術供應商之間的大量研發投資以及合作夥伴關係。值得注意的創新領域包括開發整合各種分析功能的多功能分析儀以及可提高操作靈活性的可攜式、使用者友善分析儀。儘管存在挑戰，生物加工產能的持續成長以及更環保、更永續的生產流程的趨勢仍然是推動市場向前發展的影響因素，企業準備為全球永續性做出貢獻，這強調了關注環保解決方案的重要性。

主要市場統計
基準年[2023] 5.2167 億美元
預測年份 [2024] 5.8142億美元
預測年份 [2030] 1,121,040,000 美元
複合年成長率（%） 11.54%

市場動態：快速發展的生物過程分析儀市場的關鍵市場洞察

供需的動態交互作用正在改變生物過程分析儀市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 對先進生物加工技術的需求不斷成長
    • 治療和藥物需求迅速增加
    • 對醫用重組蛋白的需求不斷成長
  • 市場限制因素
    • 原料成本上漲
  • 市場機會
    • 綜合分析設備技術進步
    • 生物技術研究的增加
  • 市場挑戰
    • 與下游生物加工相關的複雜性

波特五力：駕馭生物過程分析儀市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物過程分析儀市場的外部影響

外部宏觀環境因素在塑造生物過程分析儀市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物過程分析儀市場的競爭狀況

對生物過程分析儀市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生物過程分析儀市場供應商的績效評估

FPNV 定位矩陣是評估生物製程分析儀市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃生物過程分析儀市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，生物過程分析儀市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對先進生物加工技術的需求不斷成長
      • 對治療和藥物的需求迅速增加
      • 醫用重組蛋白的需求增加
    • 抑制因素
      • 原料成本上漲
    • 機會
      • 整合分析儀的技術進步
      • 生物技術研究的增加
    • 任務
      • 與下游生物過程相關的複雜性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物過程分析儀市場：依類型

  • 耗材及配件
  • 裝置

第7章生物過程分析儀市場：依應用分類

  • 抗生素
  • 生物相似藥
  • 重組蛋白

第8章生物過程分析儀市場：依最終用戶分類

  • 生物製藥公司
  • 契約製造組織
  • 合約調查機構

第9章美洲生物過程分析儀市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太生物製程分析儀市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲生物過程分析儀市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Aligned Genetics, Inc.
  • F. Hoffmann-La Roche AG
  • Fluorometrics Instruments, LLC by AlpHa Measurement Solutions LLC
  • Groton Biosystems, LLC
  • Kaiser Optical Systems, Inc.
  • Nova Biomedical Corporation
  • Polestar Technologies, Inc.
  • PreSens Precision Sensing GmbH
  • Randox Laboratories Ltd
  • Shimadzu Corporation
  • SYSBIOTECH GmbH
  • The Sartorius Group
  • Thermo Fisher Scientific Inc.
  • YSI, Inc.
Product Code: MRR-437D45957B0E

The Bioprocess Analyzers Market was valued at USD 521.67 million in 2023, expected to reach USD 581.42 million in 2024, and is projected to grow at a CAGR of 11.54%, to USD 1,121.04 million by 2030.

Bioprocess analyzers are critical instruments utilized in biopharmaceutical manufacturing to ensure the product's quality and consistency by monitoring variables like pH, dissolved oxygen, and cell density. The necessity of these analyzers is underscored by the stringent regulatory requirements and the growing complexity of bioprocessing techniques. They find applications in research and development, process monitoring, and quality control across the biopharmaceutical, food and beverage, and environmental sectors. The end-use scope includes biomanufacturing industries, research laboratories, and pharmaceutical companies committed to optimizing yields and complying with Good Manufacturing Practices (GMP). The market growth is notably driven by the increasing prevalence of chronic diseases, prompting higher demand for biologics, and technological advancements offering enhanced process analytical techniques. Emerging markets with expanding biopharmaceutical infrastructure, the advent of personalized medicine, and the growing trend of single-use technologies present viable opportunities. However, challenges such as high initial costs, the need for skilled personnel, and integration complexities pose significant barriers. To capitalize on growth opportunities, companies should focus on innovation in real-time and in-situ analytical solutions, increasing automation, and solutions that reduce human intervention in process monitoring. Enhanced data analytics tools that leverage AI and machine learning can also provide deeper insights and predictive capabilities, fostering more proactive process optimization. The market is dynamic and highly competitive, characterized by significant R&D investments and collaborations between biopharmaceutical firms and technology providers. Notable areas for innovation include developing multifunctional analyzers that integrate various analytical capabilities and portable and user-friendly analyzers for improved operational flexibility. Despite challenges, the continuous growth in bioprocessing capacity and the trend towards greener and more sustainable production processes remain influential factors that drive the market forward, highlighting the importance for companies to focus on eco-friendly solutions to align with global sustainability initiatives.

KEY MARKET STATISTICS
Base Year [2023] USD 521.67 million
Estimated Year [2024] USD 581.42 million
Forecast Year [2030] USD 1,121.04 million
CAGR (%) 11.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioprocess Analyzers Market

The Bioprocess Analyzers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising need for advanced bioprocess technology
    • Surge in the need for therapeutic treatment and medicines
    • Growing demand for recombinant proteins for medical applications
  • Market Restraints
    • High cost of raw materials
  • Market Opportunities
    • Technological advancement in the integrated analyzers
    • Increasing research in biotechnology
  • Market Challenges
    • Complexities associated with downstream bioprocess

Porter's Five Forces: A Strategic Tool for Navigating the Bioprocess Analyzers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioprocess Analyzers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioprocess Analyzers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioprocess Analyzers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioprocess Analyzers Market

A detailed market share analysis in the Bioprocess Analyzers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioprocess Analyzers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioprocess Analyzers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioprocess Analyzers Market

A strategic analysis of the Bioprocess Analyzers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioprocess Analyzers Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Aligned Genetics, Inc., F. Hoffmann-La Roche AG, Fluorometrics Instruments, LLC by AlpHa Measurement Solutions LLC, Groton Biosystems, LLC, Kaiser Optical Systems, Inc., Nova Biomedical Corporation, Polestar Technologies, Inc., PreSens Precision Sensing GmbH, Randox Laboratories Ltd, Shimadzu Corporation, SYSBIOTECH GmbH, The Sartorius Group, Thermo Fisher Scientific Inc., and YSI, Inc..

Market Segmentation & Coverage

This research report categorizes the Bioprocess Analyzers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Consumables & Accessories and Instruments.
  • Based on Application, market is studied across Antibiotics, Biosimilars, and Recombinant Proteins.
  • Based on End User, market is studied across Biopharmaceutical Companies, Contract Manufacturing Organizations, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising need for advanced bioprocess technology
      • 5.1.1.2. Surge in the need for therapeutic treatment and medicines
      • 5.1.1.3. Growing demand for recombinant proteins for medical applications
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the integrated analyzers
      • 5.1.3.2. Increasing research in biotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with downstream bioprocess
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioprocess Analyzers Market, by Type

  • 6.1. Introduction
  • 6.2. Consumables & Accessories
  • 6.3. Instruments

7. Bioprocess Analyzers Market, by Application

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Biosimilars
  • 7.4. Recombinant Proteins

8. Bioprocess Analyzers Market, by End User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Contract Manufacturing Organizations
  • 8.4. Contract Research Organizations

9. Americas Bioprocess Analyzers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bioprocess Analyzers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bioprocess Analyzers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Aligned Genetics, Inc.
  • 3. F. Hoffmann-La Roche AG
  • 4. Fluorometrics Instruments, LLC by AlpHa Measurement Solutions LLC
  • 5. Groton Biosystems, LLC
  • 6. Kaiser Optical Systems, Inc.
  • 7. Nova Biomedical Corporation
  • 8. Polestar Technologies, Inc.
  • 9. PreSens Precision Sensing GmbH
  • 10. Randox Laboratories Ltd
  • 11. Shimadzu Corporation
  • 12. SYSBIOTECH GmbH
  • 13. The Sartorius Group
  • 14. Thermo Fisher Scientific Inc.
  • 15. YSI, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPROCESS ANALYZERS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPROCESS ANALYZERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPROCESS ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPROCESS ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPROCESS ANALYZERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPROCESS ANALYZERS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. BIOPROCESS ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BIOPROCESS ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023